Sagimet Biosciences Inc.
General ticker "SGMT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $187.7M (TTM average)
Sagimet Biosciences Inc. follows the US Stock Market performance with the rate: 49.5%.
Estimated limits based on current volatility of 2.5%: low 6.11$, high 6.47$
Factors to consider:
- Total employees count: 10 as of 2023
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.21$, 8.25$]
- 2025-12-31 to 2026-12-31 estimated range: [2.68$, 7.05$]
Short-term SGMT quotes
Long-term SGMT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $2.00MM | $0.00MM |
| Operating Expenses | $31.05MM | $32.74MM | $54.45MM |
| Operating Income | $-31.05MM | $-30.74MM | $-54.45MM |
| Non-Operating Income | $0.56MM | $2.86MM | $8.89MM |
| R&D Expense | $24.92MM | $19.78MM | $38.44MM |
| Income(Loss) | $-30.50MM | $-27.88MM | $-45.57MM |
| Profit(Loss)* | $-30.50MM | $-27.88MM | $-45.57MM |
| Stockholders Equity | $-186.95MM | $91.06MM | $155.81MM |
| Assets | $33.03MM | $96.72MM | $160.26MM |
| Operating Cash Flow | $-24.49MM | $-23.77MM | $-42.44MM |
| Investing Cash Flow | $-32.01MM | $12.58MM | $-61.68MM |
| Financing Cash Flow | $-0.07MM | $86.17MM | $104.82MM |
| Earnings Per Share** | $-1.38 | $-1.53 | $-1.45 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.